TCL Archive In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item October 8, 1982
TCL Archive Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says October 2, 1992
TCL Archive Realities Of The 1989 Budget: Number Of grants Cut By 250, Only 255 Of Approved Will By Funded October 7, 1988
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
